Mersana Therapeutics, Inc. (MRSN)
29.06
+0.02
(+0.05%)
USD |
NASDAQ |
Dec 17, 16:00
28.94
-0.12
(-0.40%)
After-Hours: 20:00
Mersana Therapeutics Accounts Payable (Quarterly): 2.393M for Sept. 30, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Cidara Therapeutics, Inc. | 4.351M |
| Day One Biopharmaceuticals, Inc. | 5.778M |
| Cue Biopharma, Inc. | 2.348M |
| Scholar Rock Holding Corp. | 6.765M |
| ETHZilla Corp. | 1.199M |